Rigel Pharmaceuticals RIGL Single reportable segment — Other segment items
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's single reportable segment — other segment items.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Rigel Pharmaceuticals's single reportable segment — other segment items?
- Rigel Pharmaceuticals (RIGL) reported single reportable segment — other segment items of $3.35M in Q1 2026.
- What does single reportable segment — other segment items mean?
- Encompasses miscellaneous operating costs or income items that do not fall into primary expense categories. Tracking these items helps identify non-recurring or secondary operational impacts on segment performance.